M
Mangoceuticals Inc
NASDAQ:MGRX
Mangoceuticals Inc
NASDAQ:MGRX
Price:
0.3933
USD
15.68%
Market Closed
Market Cap:
$6.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Mangoceuticals Inc
NASDAQ:MGRX
|
US |
|
Valeo SE
PAR:FR
|
FR |
|
Leadtek Research Inc
TWSE:2465
|
TW |
|
Pirelli & C SpA
OTC:PLLIF
|
IT |
|
B
|
Brazil Potash Corp
AMEX:GRO
|
CA |
|
DFI Inc
TWSE:2397
|
TW |
|
Universal Power Industry Corp
OTC:UPIN
|
US |
|
G
|
Greatek Electronics Inc
TWSE:2441
|
TW |
|
Curtiss-Wright Corp
NYSE:CW
|
US |
Income Statement
Earnings Waterfall
Mangoceuticals Inc
Mangoceuticals Inc
Income Statement
Mangoceuticals Inc
Mangoceuticals Inc
Currency: USD
| Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
+98%
|
1
+47%
|
1
+16%
|
1
+3%
|
1
-13%
|
1
-18%
|
1
-17%
|
1
+1%
|
0
-10%
|
0
-2%
|
|
| Gross Profit | ||||||||||||
| Cost of Revenue |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Gross Profit |
0
N/A
|
0
+97%
|
0
+47%
|
1
+21%
|
1
-3%
|
0
-12%
|
0
-14%
|
0
-22%
|
0
+7%
|
0
-10%
|
0
-12%
|
|
| Operating Income | ||||||||||||
| Operating Expenses |
(7)
|
(8)
|
(10)
|
(10)
|
(9)
|
(9)
|
(9)
|
(11)
|
(15)
|
(20)
|
(19)
|
|
| Selling, General & Administrative |
(7)
|
(8)
|
(10)
|
(10)
|
(9)
|
(9)
|
(8)
|
(11)
|
(14)
|
(20)
|
(18)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
|
| Operating Income |
(6)
N/A
|
(7)
-13%
|
(9)
-26%
|
(9)
+2%
|
(9)
+1%
|
(9)
+0%
|
(9)
+2%
|
(11)
-29%
|
(14)
-28%
|
(20)
-41%
|
(19)
+5%
|
|
| Pre-Tax Income | ||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(6)
N/A
|
(7)
-13%
|
(9)
-26%
|
(9)
+2%
|
(9)
-1%
|
(9)
-2%
|
(9)
+7%
|
(11)
-28%
|
(14)
-27%
|
(20)
-40%
|
(21)
-4%
|
|
| Net Income | ||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(6)
|
(7)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(11)
|
(14)
|
(20)
|
(21)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(6)
N/A
|
(7)
-13%
|
(9)
-26%
|
(9)
+2%
|
(9)
-1%
|
(9)
-2%
|
(9)
+7%
|
(11)
-28%
|
(14)
-27%
|
(20)
-42%
|
(22)
-8%
|
|
| EPS (Diluted) |
-0.41
N/A
|
-0.45
-10%
|
-8.58
-1 807%
|
-5.92
+31%
|
-5.24
+11%
|
-4.63
+12%
|
-4.4
+5%
|
-2.43
+45%
|
-1.42
+42%
|
-1.74
-23%
|
-2.17
-25%
|
|
Switch to:
Switch to:
See Also
Discover More
